Home
Orbimed Advisors, Director: ARS Pharmaceuticals SPRY Buy · Filed 23/08/31
Trade details
- Type
- Insider buy
- Amount
- $3,100,000
- Shares · price
- 500,000 sh · $6.20 a share
- Held after
- 8,019,187 sh
- Person
- Orbimed AdvisorsDirector
- Trade date
- 23/08/29
- Filed
- 23/08/31
- Days to filing
- 2 days
9 insiders bought this week
- Insiders buying this week
- 9 insiders
- Holding change
- +6.6%
ARS Pharmaceuticals trades, last 26 weeks
What else happened in ARS Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 23/07/30~23/09/28Orbimed Advisors's recent trades
- Orbimed Advisors
BuyADARx Pharmaceuticals
BuyADARx Pharmaceuticals
ADRX
$10M
588,235 sh
$10M
Filed 09/30
Traded 09/28
- Orbimed Advisors
BuyADARx Pharmaceuticals
BuyADARx Pharmaceuticals
ADRX
$5.1M
300,249 sh
$5.1M
Filed 09/30
Traded 09/28
- Orbimed Advisors
BuyADARx Pharmaceuticals
BuyADARx Pharmaceuticals
ADRX
$1M
61,516 sh
$1M
Filed 09/30
Traded 09/28
- Orbimed Advisors
BuyElectra Therapeutics
BuyElectra Therapeutics
ETRA
$15M
1,000,000 sh
$15M
Filed 09/23
Traded 09/21
- Orbimed Advisors
BuyElectra Therapeutics
BuyElectra Therapeutics
ETRA
$5M
333,333 sh
$5M
Filed 09/23
Traded 09/21
